Ireland · 
Who invested in SynOx Therapeutics?
SynOx Therapeutics's investors include Forbion Capital Partners and Hercules Capital.
Ireland · Series B startup
Who invested in SynOx Therapeutics
Funding summaryUpdated 26 Oct 2026
$92Mraised across 1 round since 2024, from 1 source
- Latest round
- Series B, $92MOct 2024
- Investors
- 2
The rounds
- Oct 2024
Founders and team
From SynOx Therapeutics's own website: 10 on the team.
- Ray BarlowChief Executive Officer
- Taylor SalinardiVice President of Global Medical Affairs
- Broes NaeyeChief Technology Officer
- Elyse SeltzerChief Medical Officer
- Robert FrancomanoChief Commercial Officer
- Arthur FrankenNon-Executive Director (Gilde)
- Carl KilanderNon-Executive Director (HealthCap)
- Dirk KerstenNon-Executive Director (Forbion)
- Philip Astley-SparkeNon-Executive Chair
- Tom HeymanNon-Executive Director (BioQube)
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about SynOx Therapeutics
How much has SynOx Therapeutics raised?
SynOx Therapeutics has raised $92M across 1 round since 2024.
When did SynOx Therapeutics last raise?
SynOx Therapeutics's most recent round was a Series B of $92M in Oct 2024.
What was SynOx Therapeutics's biggest round?
Its most recent round, $92M in Oct 2024, is also its largest on record.
Who backed SynOx Therapeutics first?
SynOx Therapeutics's first round on record, in Oct 2024, was backed by Forbion Capital Partners and Hercules Capital.
What stage is SynOx Therapeutics at?
SynOx Therapeutics's latest named round is a Series B, in Oct 2024.
Where is SynOx Therapeutics based?
SynOx Therapeutics is based in Ireland.
Companies like SynOx Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.